Modeling qRT-PCR dynamics with application to cancer biomarker quantification

Area of Science:

• Biochemistry
• Molecular Biology
• Bioinformatics

Background:

• Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is crucial for molecular diagnostics and cancer prognosis.
• Accurate quantification of mRNA expression, especially for low-abundance transcripts, remains a challenge.
• Precise estimation of qRT-PCR efficiency is critical for reliable relative expression analysis.

Purpose of the Study:

• To introduce a novel approach for estimating qRT-PCR efficiency by modeling amplification dynamics.
• To improve the accuracy of mRNA quantification for low-abundance transcripts.
• To apply the new efficiency estimates in analyzing GUCY2C mRNA expression in colorectal cancer patients.

Main Methods:

• Modeling qRT-PCR amplification dynamics using an ordinary differential equation (ODE) model.
• Obtaining effective polymerase chain reaction (PCR) efficiency estimates from the fitted ODE model.
• Quantifying Guanylate Cyclase 2C (GUCY2C) mRNA expression in colorectal cancer patient blood samples.
• Analyzing the association between time to recurrence and GUCY2C expression using a joint model for survival and longitudinal data.

Main Results:

• The proposed ODE-based method provides improved estimates of qRT-PCR efficiency compared to traditional fluorescence intensity models.
• The new efficiency estimates enabled accurate quantification of GUCY2C mRNA expression.
• The joint model, incorporating GUCY2C expression quantified with the novel efficiency estimates, revealed clinically meaningful associations with time to recurrence in colorectal cancer patients.

Conclusions:

• The developed ODE-based modeling approach offers a more accurate method for estimating qRT-PCR efficiency.
• This advancement improves the reliability of mRNA expression analysis, particularly for low-abundance targets.
• The findings support the clinical utility of this enhanced qRT-PCR quantification method for cancer biomarker discovery and prognosis.